1. Home
  2. VCYT vs PHIN Comparison

VCYT vs PHIN Comparison

Compare VCYT & PHIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCYT
  • PHIN
  • Stock Information
  • Founded
  • VCYT 2006
  • PHIN 2023
  • Country
  • VCYT United States
  • PHIN United States
  • Employees
  • VCYT 824
  • PHIN N/A
  • Industry
  • VCYT Medical Specialities
  • PHIN
  • Sector
  • VCYT Health Care
  • PHIN
  • Exchange
  • VCYT Nasdaq
  • PHIN Nasdaq
  • Market Cap
  • VCYT 2.4B
  • PHIN 2.0B
  • IPO Year
  • VCYT 2013
  • PHIN N/A
  • Fundamental
  • Price
  • VCYT $30.22
  • PHIN $55.27
  • Analyst Decision
  • VCYT Buy
  • PHIN Buy
  • Analyst Count
  • VCYT 9
  • PHIN 5
  • Target Price
  • VCYT $39.89
  • PHIN $54.60
  • AVG Volume (30 Days)
  • VCYT 2.4M
  • PHIN 457.9K
  • Earning Date
  • VCYT 08-06-2025
  • PHIN 07-24-2025
  • Dividend Yield
  • VCYT N/A
  • PHIN 1.95%
  • EPS Growth
  • VCYT N/A
  • PHIN 59.07
  • EPS
  • VCYT 0.34
  • PHIN 2.56
  • Revenue
  • VCYT $479,129,000.00
  • PHIN $3,358,000,000.00
  • Revenue This Year
  • VCYT $12.57
  • PHIN $0.12
  • Revenue Next Year
  • VCYT $10.23
  • PHIN $2.00
  • P/E Ratio
  • VCYT $90.02
  • PHIN $21.64
  • Revenue Growth
  • VCYT 19.91
  • PHIN N/A
  • 52 Week Low
  • VCYT $22.61
  • PHIN $36.25
  • 52 Week High
  • VCYT $47.32
  • PHIN $57.23
  • Technical
  • Relative Strength Index (RSI)
  • VCYT 67.14
  • PHIN 69.68
  • Support Level
  • VCYT $26.61
  • PHIN $48.94
  • Resistance Level
  • VCYT $30.73
  • PHIN $56.29
  • Average True Range (ATR)
  • VCYT 1.17
  • PHIN 1.33
  • MACD
  • VCYT 0.75
  • PHIN 0.33
  • Stochastic Oscillator
  • VCYT 93.47
  • PHIN 86.16

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

About PHIN PHINIA Inc.

Phinia Inc is engaged in the development, design, and manufacture of integrated components and systems that optimize performance, increase efficiency, and reduce emissions in combustion and hybrid propulsion for commercial vehicles, industrial applications, and light vehicles. Its product portfolio includes alternative fuel systems, fuel delivery modules, evaporative canisters, diesel fuel injection systems, electrical systems, hydrogen solutions, associated software, and others. The company's reportable segments are; the Fuel Systems segment, which derives key revenue, and the Aftermarket segment. Geographically, the company generates maximum revenue from the United States and the rest from the United Kingdom, China, Poland, Romania, Brazil, and other regions.

Share on Social Networks: